TopNews

Glenmark Pharmaceuticals SA has successfully completed Phase-I clinical trials of its new molecule, GRC 15300, which has been developed for treatment of neuropathic pain. GRC 15300 is a first in–class inhibitor for treatment of pain.

Chairman and Managing Director of the company, Mr. Glenn Saldanha, said that GRC 15300 is the first TRPV3 inhibitor across the globe. Glenmark done its Phase-1 analysis in UK and Saldanha said that they have plans to start the clinical proofing of the study.

Wheat yesterday traded with the positive node and settled 0.3% up at 1206 as short

The Spokesman of Swiss National Bank, Walter Meier, reveals to Press Trust of India, a news agency, that the deposits from India amounted to $2.5 billion Swiss francs ($2.5 billion) at the Swiss National Bank by the end of 2010.

The total of $2.1 billion comprised of savings and deposits from the companies, financial organisation and individuals. The left over $400 million represented deposits in Swiss accounts held by wealth managers on behalf of Indian clients.

Crude Palm oil yesterday traded with the positive node and settled 0.49% u

Due to holding and cancelling of various major environmental projects, the Indian market has experienced several annoyed investors and therefore worried markets. Therefore, the PM finally has decided to set up an independent environmental regulator who, by reviewing the investment projects for clearance, would flee the government from this phase of making unpopular choices. Yes, sometimes the government is forced to make a choice between spurring development and protection to ecology, which becomes a difficult decision for it.

Ref Soyaoil yesterday traded with the positive node and settle